Investor directory

Accelmed

Accelmed is a venture capital firm established in 2009 by Mori Arkin and Uri Geiger, headquartered in New York with a presence in Tel Aviv. The firm specializes in funding private and public medical device companies that exhibit significant market potential and have demonstrated clinical data. By focusing on companies that have already reached the revenue stage, Accelmed provides both managerial expertise and financial resources, facilitating the transition from clinical development to profitable operations. The firm collaborates closely with the management teams of its portfolio companies to develop clear commercial strategies, ultimately aiming to accelerate their journey towards successful exits. Accelmed's investment strategy emphasizes growth-oriented opportunities in the healthcare, life sciences, and technology sectors across Israel and the United States.

Focus

Scale StageLate StageSeries DRoboticsRoboticsShow more
http://www.accelmed.co.il
https://crunchbase.com/organization/accelmed
https://linkedin.com/company/accelmed
https://www.privateequityinternational.com/database/#/profile?id=12287

Nir Gilad

Investment Manager

Evan Norton

General Partner

Torgovicky M.B.A., M.D., Rafael

General Partner

39 past transactions

Medical Compression Systems

Post in 2010
Medical Compression Systems (MCS) Ltd. provides solutions for the prevention of deep vein thrombosis (DVT) and venous thromboembolism (VTE). The company’s product pipeline includes ActiveCare+S.F.T., a non-pharmaceutical mechanical solution that provides the prevention of DVT/VTE for in and out of hospital patient settings; and ActiveCare+DTx, which prevents DVT, as well as identifies proximal venous flow obstruction. Its product pipeline also comprises the ActiveCast, a device for bone fracture treatment; and the ActiveCare Vascular, a device used in the outpatient wound care market.

CartiHeal

Series D in 2012
Cartiheal Ltd., a medical device company, develops implants for the regeneration of cartilage and bone disorders. The company offers Agili-C, an off the shelf and cell-free implant that regenerates hyaline cartilage and its underlying subchondral bone. Its implant is used for the treatment of focal articular cartilage and osteochondral defects. The company was founded in 2009 and is based in Kfar Sava, Israel.

NeuroPace

Private Equity Round in 2020
NeuroPace, Inc. designs, develops, manufactures, and markets implantable devices for the treatment of neurological disorders with responsive stimulation. It offers RNS System, a medical device that monitors and responds to brain activity. The company’s RNS System consists of a small implantable neuro stimulator that is connected to leads that are placed in up to two seizure onset areas. NeuroPace, Inc. was founded in 1997 and is based in Mountain View, California.

CartiHeal

Venture Round in 2013
Cartiheal Ltd., a medical device company, develops implants for the regeneration of cartilage and bone disorders. The company offers Agili-C, an off the shelf and cell-free implant that regenerates hyaline cartilage and its underlying subchondral bone. Its implant is used for the treatment of focal articular cartilage and osteochondral defects. The company was founded in 2009 and is based in Kfar Sava, Israel.

ValCare, Inc.

Venture Round in 2012
ValCare, Inc., a medical device company, designs and develops devices and accessories for minimally invasive treatment of heart valve disease. The company was founded in 2012 and is based in Irvine, California.

MedMinder Systems

Private Equity Round in 2021
MedMinder Systems provides services that simplify medication management and improve medication adherence. It offers an automatic pill dispenser that reminds users when it is time to take their medication through flashes, beeps, text messages, and phone calls. It also provides the user's caregivers, family members, or pharmacists with notifications about their dosage activity, which can be monitored remotely through a patient profile's on MedMinder's website. The company was founded in 2007 and is headquartered in Needham, Massachusetts.

EndoChoice

Venture Round in 2011
ECPM is a medical device company focused on designing and commercializing a platform of products and services for gastrointestinal caregivers. The Company offers a range of products and services that span single-use devices and infection control products, pathology, and imaging systems. Its products are used in colonoscopy and procedures of the upper GI tract, including esophagogastroduodenoscopy (EGD). The company is headquartered in Alpharetta, Georgia.

Digma Medical

Seed Round in 2013
Digma Medical is a clinical stage medical device company revolutionizing the treatment of Type-2 Diabetes and other metabolic syndrome disease such as NASH. Founded in 2013 and backed by leading venture capital firms, Digma is dedicated to the development of the DiaGone™ to treat insulin resistance - the underlying mechanism of the disease. The DiaGone™ is an endoscopic, disposable device, that uses state of the art laser technology to treat the duodenum without an implant. The Duodenal Glycemic Control™ procedure is a one-time 30 minute GI procedure, in which the gastroenterologist uses the DiaGone™ to treat the duodenum for restoring the natural ability of the body to control glucose levels, which may provide long term remission from Type-2 Diabetes, NASH, and other metabolic syndrome related disease.

Cogentix Medical

Post in 2016
Cogentix Medical products have increased treatment efficiency and lowered patient risk. Macroplastique® established the European market for bulking agents, EndoSheath® protective barrier redefined endoscopy and Urgent® PC set the standard for percutaneous tibial nerve stimulation (PTNS) as a treatment for Overactive Bladder. Cogentix Medical was formed in 2015 following a merger of Uroplasty and Vision-Sciences.

EndoGastric Solutions

Series I in 2019
EndoGastric Solutions, Inc. (www.endogastricsolutions.com), is a medical device company developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of GERD. EGS has combined the most advanced concepts in gastroenterology and surgery to develop the Transoral Incisionless Fundoplication (TIF®) 2.0 procedure—a minimally invasive solution that addresses a significant unmet clinical need. EndoGastric Solutions, Inc. was founded in 2003 and is headquartered in Redmond, Washington.

Memic Innovative Surgery

Series D in 2021
Memic Innovative Surgery develops and delivers robotic surgical solutions designed to enable otherwise infeasible surgical procedures. Its first offering facilitates a variety of robotic gynecological procedures via a vaginal approach, expanding the feasibility of vaginal surgery to the vast majority of cases. Its robotic technology consists of miniature and humanoid-shaped articulated arms that mimic human dexterity while surpassing human flexibility. The robotic arms are controllable via various proprietary control consoles to maintain natural control of the arms, allowing surgeons to operate precisely in tight anatomical spaces with decreased risk to nearby organs and tissue.

BioProtect

Series D in 2020
BioProtect Ltd. is an international medical device startup. It is primarily engaged in to the business of developing and commercializing biodegradable balloon spacers for the protection of normal tissue during cancer radiation therapy. The company's current focus in the growing radiotherapy spacers market, where its ProSpace balloon spacer (CE marked) has shown superior efficacy and safety in protecting the rectum during radiation therapy for prostate cancer. The company's technology platform of biodegradable implantable balloons suits a wide range of applications for unmet clinical needs. BioProtect was founded in the year 2004 and headquartered in Israel, with subsidiaries in Germany and US.

Cynerio

Series B in 2021
Cynerio develops a platform that enables healthcare providers to secure patient data and connected medical devices against cyber threats. Its platform provides device behavior learning with medical workflow analysis to provide full visibility of what devices are doing on the network and associated risk, detecting anomalous activity, and stopping the threat. Daniel Brodie and Leon Lerman founded Cynerio in 2017.Its headquarters is in Tel Aviv in Israel.

CartiHeal

Series A in 2009
Cartiheal Ltd., a medical device company, develops implants for the regeneration of cartilage and bone disorders. The company offers Agili-C, an off the shelf and cell-free implant that regenerates hyaline cartilage and its underlying subchondral bone. Its implant is used for the treatment of focal articular cartilage and osteochondral defects. The company was founded in 2009 and is based in Kfar Sava, Israel.

EndoChoice

Series D in 2015
ECPM is a medical device company focused on designing and commercializing a platform of products and services for gastrointestinal caregivers. The Company offers a range of products and services that span single-use devices and infection control products, pathology, and imaging systems. Its products are used in colonoscopy and procedures of the upper GI tract, including esophagogastroduodenoscopy (EGD). The company is headquartered in Alpharetta, Georgia.

Cynerio

Seed Round in 2019
Cynerio develops a platform that enables healthcare providers to secure patient data and connected medical devices against cyber threats. Its platform provides device behavior learning with medical workflow analysis to provide full visibility of what devices are doing on the network and associated risk, detecting anomalous activity, and stopping the threat. Daniel Brodie and Leon Lerman founded Cynerio in 2017.Its headquarters is in Tel Aviv in Israel.

EndoChoice

Venture Round in 2013
ECPM is a medical device company focused on designing and commercializing a platform of products and services for gastrointestinal caregivers. The Company offers a range of products and services that span single-use devices and infection control products, pathology, and imaging systems. Its products are used in colonoscopy and procedures of the upper GI tract, including esophagogastroduodenoscopy (EGD). The company is headquartered in Alpharetta, Georgia.

CartiHeal

Venture Round in 2012
Cartiheal Ltd., a medical device company, develops implants for the regeneration of cartilage and bone disorders. The company offers Agili-C, an off the shelf and cell-free implant that regenerates hyaline cartilage and its underlying subchondral bone. Its implant is used for the treatment of focal articular cartilage and osteochondral defects. The company was founded in 2009 and is based in Kfar Sava, Israel.

Corvia Medical

Series D in 2014
Corvia Medical is a medical device company, focuses on developing structural heart devices for the treatment of heart failure. The company develops InterAtrial Shunt Device (IASD), a transcatheter device designed to treat diastolic heart failure (DHF), also known as heart failure with preserved ejection fraction (HFpEF). It was founded in 2009 and headquartered in Andover, Massachusetts.

Strata Skin Sciences

Post in 2018
STRATA Skin Sciences is a medical technology company focused on the dermatology market. Its products include the XTRAC® laser and VTRAC® excimer lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions; and the MelaFind® system used to assist in the identification and management of melanoma skin cancer.

Revamp Medical

Series A in 2023
Revamp medical was founded in 2016 with the goal of resolving one of the most urgent unmet needs in Acute Heart Failure patients. Targeting a market of >1M annual admissions in the US with a direct cost of $65B, Revamp is set to deliver an easily adoptable solution using its patented temporary catheter, Doraya™. Revamp has a seasoned team of professionals with a proven track record in leading multiple med-tech startups.

Minerva Surgical

Post in 2022
Minerva Surgical Inc., a medical technology company, develops products for women’s healthcare. It offers The Minerva Endometrial Ablation System, a product for the treatment of abnormal uterine bleeding in women. Minerva Surgical Inc. was founded in 2008 and is based in Redwood City, California.

MedMinder Systems

Venture Round in 2022
MedMinder Systems provides services that simplify medication management and improve medication adherence. It offers an automatic pill dispenser that reminds users when it is time to take their medication through flashes, beeps, text messages, and phone calls. It also provides the user's caregivers, family members, or pharmacists with notifications about their dosage activity, which can be monitored remotely through a patient profile's on MedMinder's website. The company was founded in 2007 and is headquartered in Needham, Massachusetts.

Diagnostic Robotics

Series B in 2022
Diagnostic Robotic develops a signal-agnostic artificial intelligence system for healthcare insurers, providers, and patients. It allows to build powerful predictive analytics models that will solve a world-wide challenge, strained health budgets, and workforces. Diagnostic Robotic was founded on 2017 and is headquartered in Tel Aviv, Israel.

Diagnostic Robotics

Series A in 2019
Diagnostic Robotic develops a signal-agnostic artificial intelligence system for healthcare insurers, providers, and patients. It allows to build powerful predictive analytics models that will solve a world-wide challenge, strained health budgets, and workforces. Diagnostic Robotic was founded on 2017 and is headquartered in Tel Aviv, Israel.

Eximo Medical

Series A in 2015
Eximo Medical Ltd. develops hybrid catheter technology for tissue resection invascular and gastrointestinal endoluminal applications. The company’s technology includes CatHI, a single-use hybrid catheter that provides optical fibers that deliver short laser pulse, and a blunt mechanical knife. Its clinical applications also comprise lead extraction and peripheral artery disease. The company was founded in 2012 and is based in Modi'in-Maccabim-Re'ut, Israel. As of October 2, 2019, Eximo Medical Ltd. operates as a subsidiary of AngioDynamics, Inc.

Veranex

Private Equity Round in 2022
Veranex is the first truly end-to-end, global, tech-enabled, concept-through-commercialization service provider that focuses solely on medical technology: medical device, diagnostics, companion diagnostics, digital health, and drug delivery. For all your needs through the entire medical device clinical trial process, Veranex is transforming medtech innovations.

TailorMed

Venture Round in 2021
TailorMed is a health IT company that works with providers, pharmacies and manufacturers to reduce patient financial toxicity and create efficiencies across the patient treatment lifecycle. Our end-to-end platform applies algorithms and automations to make the co-pay assistance and free drug order processes seamless and leverages our deep data set to create actionable insights.

MedMinder Systems

Private Equity Round in 2021
MedMinder Systems provides services that simplify medication management and improve medication adherence. It offers an automatic pill dispenser that reminds users when it is time to take their medication through flashes, beeps, text messages, and phone calls. It also provides the user's caregivers, family members, or pharmacists with notifications about their dosage activity, which can be monitored remotely through a patient profile's on MedMinder's website. The company was founded in 2007 and is headquartered in Needham, Massachusetts.

Keystone Dental

Venture Round in 2021
Keystone Dental was founded in March 2006, and aspires to build a market leading, global brand recognized within the dental community for its integrity, trust and commitment to improving the standard of care for patients and their quality of life. Since then, they have rapidly grown into a diversely skilled, fast-moving team of professionals committed to providing excellent customer service and producing high-quality products and services.

SoniVie

Venture Round in 2015
SoniVie is developing an advanced denervation solution to treat pulmonary hypertension.

Pi-Cardia

Series B in 2011
Pi-Cardia is a medical device start-up company developing a novel low profile catheter for the treatment of aortic stenosis. The company's proprietary technology is based on delivering mechanical impact for creating fractures in valve calcifications, without injuring the surrounding soft tissue. This treatment, which only takes several seconds, is intended to increase the valve effective orifice area without the need to replace the valve.

Memic Innovative Surgery

Series D in 2021
Memic Innovative Surgery develops and delivers robotic surgical solutions designed to enable otherwise infeasible surgical procedures. Its first offering facilitates a variety of robotic gynecological procedures via a vaginal approach, expanding the feasibility of vaginal surgery to the vast majority of cases. Its robotic technology consists of miniature and humanoid-shaped articulated arms that mimic human dexterity while surpassing human flexibility. The robotic arms are controllable via various proprietary control consoles to maintain natural control of the arms, allowing surgeons to operate precisely in tight anatomical spaces with decreased risk to nearby organs and tissue.

NLT SPINE

Venture Round in 2012
NLT SPINE, a clinical stage VC-backed company, specializes in the development and marketing of innovative Minimally Invasive Spinal Surgery (MISS) products for treating degenerative spinal conditions. The company's vision is to improve patient care by shifting from traditional open surgical routines to MISS, employing new methods and technologies to enhance safety, predictability and outcomes.

Click Therapeutics

Series B in 2021
Click Therapeutics, Inc. engineers, validates, develops, and commercializes digital therapeutics solutions to benefit people with unmet medical needs through cognitive and neurobehavioral modification. It develops and commercializes novel digital therapeutics for various indications, including smoking cessation, major depressive disorders, schizophrenia, insomnia, acute coronary syndrome, migraine, overactive bladder, chronic low back pain, and obesity. Click Therapeutics, Inc. was founded in 2012 and is based in New York, New York.

Digma Medical

Series A in 2015
Digma Medical is a clinical stage medical device company revolutionizing the treatment of Type-2 Diabetes and other metabolic syndrome disease such as NASH. Founded in 2013 and backed by leading venture capital firms, Digma is dedicated to the development of the DiaGone™ to treat insulin resistance - the underlying mechanism of the disease. The DiaGone™ is an endoscopic, disposable device, that uses state of the art laser technology to treat the duodenum without an implant. The Duodenal Glycemic Control™ procedure is a one-time 30 minute GI procedure, in which the gastroenterologist uses the DiaGone™ to treat the duodenum for restoring the natural ability of the body to control glucose levels, which may provide long term remission from Type-2 Diabetes, NASH, and other metabolic syndrome related disease.

Cynerio

Seed Round in 2018
Cynerio develops a platform that enables healthcare providers to secure patient data and connected medical devices against cyber threats. Its platform provides device behavior learning with medical workflow analysis to provide full visibility of what devices are doing on the network and associated risk, detecting anomalous activity, and stopping the threat. Daniel Brodie and Leon Lerman founded Cynerio in 2017.Its headquarters is in Tel Aviv in Israel.

TearLab

Acquisition in 2020
TearLab Corporation develops and markets lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care. The TearLab Osmolarity Test, for diagnosing Dry Eye Disease, is the first assay developed for the award winning TearLab Osmolarity System. Headquartered in San Diego, CA, TearLab Corporation's common shares trade on the NASDAQ Capital Market under the symbol TEAR and on the Toronto Stock Exchange under the symbol TLB.

MedMinder Systems

Debt Financing in 2022
MedMinder Systems provides services that simplify medication management and improve medication adherence. It offers an automatic pill dispenser that reminds users when it is time to take their medication through flashes, beeps, text messages, and phone calls. It also provides the user's caregivers, family members, or pharmacists with notifications about their dosage activity, which can be monitored remotely through a patient profile's on MedMinder's website. The company was founded in 2007 and is headquartered in Needham, Massachusetts.